Coherus Oncology Files 8-K with Corporate Updates
Ticker: CHRS · Form: 8-K · Filed: May 30, 2025 · CIK: 1512762
Sentiment: neutral
Topics: corporate-filing, bylaws, financials
TL;DR
Coherus Oncology filed an 8-K on 5/29/25 for corporate updates and financial filings.
AI Summary
Coherus Oncology, Inc. filed an 8-K on May 29, 2025, reporting amendments to its articles of incorporation or bylaws, a Regulation FD disclosure, and financial statements/exhibits. The company, formerly known as Coherus BioSciences, Inc. and BioGenerics, Inc., is incorporated in Delaware and has a fiscal year end of December 31.
Why It Matters
This filing indicates potential changes in the company's corporate structure or governance, which could impact its operational and financial reporting.
Risk Assessment
Risk Level: low — The filing is routine and pertains to corporate record-keeping and disclosures, not immediate operational or financial distress.
Key Numbers
- 001-36721 — SEC File Number (Identifier for Coherus Oncology, Inc.'s SEC filings)
- 27-3615821 — EIN (Employer Identification Number for Coherus Oncology, Inc.)
Key Players & Entities
- Coherus Oncology, Inc. (company) — Registrant
- Coherus BioSciences, Inc. (company) — Former Company Name
- BioGenerics, Inc. (company) — Former Company Name
- Dennis M. Lanfear (person) — Contact Person
- May 29, 2025 (date) — Date of Report
FAQ
What specific amendments were made to Coherus Oncology, Inc.'s articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the nature of the Regulation FD disclosure mentioned in the filing?
The provided text does not specify the content of the Regulation FD disclosure.
When was Coherus Oncology, Inc. previously known as Coherus BioSciences, Inc. and BioGenerics, Inc.?
The company was formerly Coherus BioSciences, Inc. as of January 14, 2013, and prior to that, BioGenerics, Inc. as of February 10, 2011.
What is the primary business of Coherus Oncology, Inc. according to its SIC code?
Coherus Oncology, Inc. is classified under SIC code 2836, which pertains to Biological Products (No Diagnostic Substances).
Where is Coherus Oncology, Inc. incorporated and what is its fiscal year end?
The company is incorporated in Delaware and its fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 by Dennis M. Lanfear regarding Coherus Oncology, Inc. (CHRS).